Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 2/20 | 0.51 |
| ▸ | FAAH | O00519 | 4/20 | 0.50 |
| ▸ | CASP2 | P42575 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.47 |
| ▸ | NAAA | Q02083 | 1/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.45 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | CTSD | P07339 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25825165 | 0.96 | FAAH (0.55) | CNR1FAAHCASP2TSHRDNM1 | |
| SCHEMBL29637706 | 0.94 | FAAH (0.58) | CNR1FAAHCASP2DNM1NAAA | |
| SCHEMBL29637697 | 0.94 | FAAH (0.58) | CNR1FAAHCASP2DNM1NAAA | |
| SCHEMBL29637720 | 0.94 | FAAH (0.58) | CNR1FAAHCASP2DNM1NAAA | |
| SCHEMBL16924465 | 0.94 | FAAH (0.58) | CNR1FAAHCASP2DNM1NAAA | |
| SCHEMBL29637705 | 0.94 | FAAH (0.58) | CNR1FAAHCASP2DNM1NAAA | |
| Hexadecanoic Acid Propylamide SCHEMBL16398673 | 0.90 | FAAH (0.65) | CNR1FAAHCASP2DNM1NAAA | |
| SCHEMBL6686395 | 0.89 | CASP2 (0.59) | CNR1FAAHCASP2TSHRDNM1 | |
| SCHEMBL1298444 | 0.89 | CASP2 (0.47) | CNR1FAAHCASP2DNM1NAAA | |
| SCHEMBL24312136 | 0.87 | CTSD (0.60) | CNR1FAAHCASP2TSHRDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022038417-A2 | MODIFIED IL-18 POLYPEPTIDES AND USES THEREOF | BRIGHT PEAK THERAPEUTICS AG (CH) | 2022-02-24 | — | — | WO | disclosed |
| EP-3733683-A1 | NUCLEOSIDE ANALOGUE, PREPARATION METHOD AND APPLICATION | GeneMind Biosciences Company Limited (CN) | 2020-11-04 | — | — | EP | disclosed |
| EP-2460885-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE 3-SUBSTITUTED GLUTARIC ACID MONOAMIDE | Kaneka Corporation (JP) | 2012-06-06 | — | — | EP | disclosed |